Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials

Dermatology and Therapy - Germany
doi 10.1007/s13555-017-0187-0
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Systemic Combination Treatment for Psoriasis: A Review

Acta Dermato-Venereologica
DermatologyMedicine
2010English

Safety of Guselkumab in Patients With Psoriasis Treated Through 100 Weeks

British Journal of Dermatology
DermatologyMedicine
2019English

Efficacy and Safety of Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma: A Systematic Review of Phase II Trials

PLoS ONE
Multidisciplinary
2012English

P-148Recurrence Free Survival as a Putative Surrogate for Overall Survival in Phase III Trials of Curative – Intent Treatment of Colorectal Liver Metastases: Systematic Review

Annals of Oncology
MedicineOncologyHematology
2016English

Phase III Trials of Targeted Anticancer Therapies: Redesigning the Concept

Clinical Cancer Research
Cancer ResearchOncology
2013English

Reporting of Quality of Life in Clinical Trials of Biologics for Plaque Psoriasis: A Systematic Review

SKIN The Journal of Cutaneous Medicine
2018English

A Novel Vehicle for the Treatment of Psoriasis

Dermatologic Therapy
DermatologyMedicine
2019English

Immunosuppressants for the Treatment of Psoriasis

Journal of Nihon University Medical Association
2017English

What Phase III Trials Are Needed to Improve the Treatment of Advanced Non-Small-Cell Lung Cancer?

Nature Clinical Practice Oncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy